23 results
Thumbnail

D2.63 - Airborne allergic contact dermatitis in a textile worker: role of formaldehyde and methylisothiazolinones

Thumbnail

D2.64 - Occupational allergic contact dermatitis due to rubber additives: clinical features and occupational implications

Thumbnail

D2.72 - Radiological heterogeneity and inflammatory phenotypes in allergic bronchopulmonary aspergillosis

Thumbnail

D2.58 - Nickel Sensitization and Reversible Airway Dysfunction: Evidence from Pulmonary Function Response to Nickel Avoidance

Thumbnail

D2.59 - Refining Quality of Life Assessment in CSU: Validation and Threshold Determination of the CU-Q2oL questionnaire

Thumbnail

D2.61 - Allergic Contact Dermatitis Due to Disperse Textile Dyes: A 10-Year Review

Thumbnail

D2.62 - Atypical Chronic Cheilitis as Manifestation of Atopic Dermatitis: A Diagnostic Dilemma

Thumbnail

D2.65 - Allergic cheilitis related to vaginal lubricant: a case report

Thumbnail

D2.66 - Allergic contact dermatitis to cobalt and concomitant sensitization to nickel and chromium

Thumbnail

D2.67 - Clinical Profile of Allergic Contact Dermatitis in Workers and Factors Associated with Occupational Outcomes

Thumbnail

D2.432 - Therapeutic Efficacy of Platelet-Rich Plasma in Androgenic Alopecia: A Meta-Analysis of Single Versus Double-Blinded Randomized Controlled Trials

Thumbnail

D2.423 - Changes in the expression of regulatory receptors on CD8+ T cytotoxic lymphocytes as a marker of the risk of developing a post COVID-19 condition in patients after a severe course of COVID-19

Thumbnail

D2.427 - Inhibition of the IL-17 pathway in the treatment of systemic vasculitis: molecular biology and case review

Thumbnail

D2.429 - Virus-Specific Regulatory T-Cell Dysregulation in Post-COVID-19 and EBV-Associated Vasculitis

Thumbnail

D2.430 - Automated 24-Hour Quantification of Scratching Behavior Reveals Distinct Physiological and Allergic Pruritus Signatures in Mice

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project